William P. Forbes - 31 Oct 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Chief Development Officer
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
Issuer symbol
HRTX
Transactions as of
31 Oct 2025
Net transactions value
$0
Form type
4
Filing time
04 Nov 2025, 12:35:32 UTC
Previous filing
21 Oct 2025
Next filing
06 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Forbes William P EVP, Chief Development Officer 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/ Kathryn Lester Attorney-in-Fact for William P. Forbes 04 Nov 2025 0001314760

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +11,694 +7.6% 166,203 31 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -11,694 -7.1% $0.000000 152,027 31 Oct 2025 Common Stock 11,694 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).